Levels of vancomycin in the cerebral interstitial fluid after severe head injury

Intensive Care Medicine

Volumn 32, Issue 2, 2006, Pages 325-328

  Caricato, Anselmo ^a   Pennisi, Mariano ^a   Mancino, Aldo ^a   Vigna, Gianluca ^a   Sandroni, Claudio ^a   Arcangeli, Andrea ^a   Antonelli, Massimo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Blood brain barrier; Cerebral interstitial fluid; Cerebral posttraumatic hemorrhage; Microdialysis; Severe head injury; Vancomycin

Indexed keywords

VANCOMYCIN;

ABDOMEN; ADULT; ARTICLE; BLEEDING; BRAIN EDEMA; CASE REPORT; CATHETER; CRANIOTOMY; DRUG BLOOD LEVEL; HEAD INJURY; HUMAN; INTERSTITIAL FLUID; MALE; MICRODIALYSIS; MINIMUM INHIBITORY CONCENTRATION; PNEUMONIA; SUBCUTANEOUS TISSUE;

ADULT; ANTI-BACTERIAL AGENTS; BLOOD-BRAIN BARRIER; CRANIOCEREBRAL TRAUMA; CRANIOTOMY; EXTRACELLULAR FLUID; HUMANS; MALE; MICRODIALYSIS; PROSPECTIVE STUDIES; VANCOMYCIN;

EID: 32844464244     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-005-0015-3     Document Type: Article

References (20)

1. Povlishock JT (1998) The pathophysiology of blood-brain barrier dysfunction due to traumatic brain injury. In: Pardridge WM (ed) Introduction to the blood-brain barrier; methodology, biology and pathology. Cambridge University Press, Cambridge, pp 441-453
2. Bouw R, Ederoth P, Lundberg J, Ungerstedt U, Nordstrom CH, Hammarlud-Udenaes M (2001) Increased blood-brain barrier permeability of morphine in a patient with severe brain lesions as determined by microdialysis. Acta Anaesthesiol Scand 45:390-392
3. Begg EJ, Barclay ML, Kirkpatrick CJM (1999) The therapeutic monitoring of antimicrobial agents. Br J Clin Pharmacol 47:23-30
4. British National Formulary (2005) British national formulary, vol 49. British Medical Association and Royal Pharmaceutical Society of Great Britain, London
5. Abbott NJ, Romero A (1996) Transporting therapeutics across the blood-brain barrier. Mol Med Today 2:106-113
6. Lutsar I, McCracken GH Jr, Friedland IR (1998) Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis 27:1117-1129
7. Albanese J, Leone M, Bruguerolle B, Ayem M, Lacarelle B, Martin C (2000) Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an Intensive Care Unit. Antimicrob Agents Chemother 44:1356-1358
8. Moellering RC, Krigstad DJ, Greenblatt DJ (1981) Vancomycin therapy in patients with impaired renal function: a nomogram for dosage. Ann Intern Med 94:343-346
9. Strausbaugh LJ, Murray TW, Sande MA (1981) Comparative penetration of 6 antibiotics into the CSF of rabbits with experimental staphylococcal meningitis. J Antimicrob Chemother 6:363-371
10. Mackie CE, English HE, Lelievre E, Gordon BH, Genissel P, Robinson BV(1997) Radioimmunoassay for the measurement of S9788 in serum and microdialysis samples. J Pharm Biomed Anal 15:917-928
11. Rocha LL, Evans CJ, Maidment NT (1997) Amygdala kindling modifies extracellular opioid peptide content in rat hippocampus measured by microdialysis. J Neurochem 68:616-624
12. Davies MI, Cooper JD, Desmond SS, Lunte CE, Lunte SM (2000) Analytical considerations for microdialysis sampling. Adv Drug Deliv Rev 45:169-188
13. Plock N, Buerger C, Kloft C (2005) Successful management of discovered pH dependence in vancomycin recovery studies: novel HPLC method for microdialysis and plasma samples. Biomed Chromatogr 19:237-244
14. Peetermans WE, Hoogeterp JJ, Hazekamp-Van Dokkum AM (1990) Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in experimental infection. Antimicrob Agents Chemother 34:1869-1874
15. Ackerman BH, Vannier AM, Eudy EB (1992) Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response. Antimicrob Agents Chemother 36:1766-1769
16. Stratton CW, Liu C, Weeks S (1987) Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies. Antimicrob Agents Chemother; 31:1210-1215
17. Iwamoto T, Kagawa Y, Kojima M (2003) Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. Biol Pharm Bull 26:876-879
18. Tobin CM, Darville JM, Thomson AH, Sweeney G, Wilson JF, MacGowan AP, White LO (2002) Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire. J Antimicr Chemotherapy 50:713-718
19. De Lange ECM, Danhof M (2002) Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting. Clin Pharmacokinet 41:691-703
20. Eftekhar B, Ghodsi M, Nejat F, Ketabchi E, Esmaeeli B (2004) Prophylactic administration of ceftriaxone for the prevention of meningitis after traumatic pneumocephalus: results of a clinical trial. J Neurosurg 101:757-761